Skip to main content
Clearmind Medicine Inc. logo

Clearmind Medicine Inc. — Investor Relations & Filings

Ticker · CMND ISIN · CA1850534027 LEI · 8945006FVE3FLKX9BN50 US Manufacturing
Open in API
Filings indexed 301 across all filing types
Latest filing 2026-06-01 Regulatory Filings
Country CA Canada
Listing US CMND

About Clearmind Medicine Inc.

https://www.clearmindmedicine.com/

Clearmind Medicine Inc. is a clinical-stage psychedelic pharmaceutical company focused on developing novel psychedelic-derived therapeutics for under-served health problems. The company's primary objective is the research and development of treatments for binge behaviors and mental health conditions, with a lead focus on Alcohol Use Disorder (AUD). Its main therapeutic candidate, CMND-100, is based on the proprietary psychoactive molecule MEAI (5-Methoxy-2-aminoindane). MEAI is designed to produce an alcohol-like euphoric experience while reducing the desire to consume alcohol. The company is advancing CMND-100 in a Phase I/IIa clinical trial for AUD. Clearmind's development pipeline is supported by a portfolio of 19 patent families.

Recent filings

Filing Released Lang Actions
FORM 6-K
Regulatory Filings Classification · 90% confidence The document is a Form 6-K “Report of Foreign Private Issuer” filed with the U.S. SEC, announcing amendments to securities purchase agreements and convertible promissory note financings. It does not contain the full financial statements of an annual or interim report, nor a proxy, earnings release, or detailed investor presentation. It is a regulatory compliance filing and thus falls under the fallback category “Regulatory Filings” (RNS).
2026-06-01 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 92% confidence The document is an SEC Form 6-K “Report of Foreign Private Issuer” submitted under the Securities Exchange Act of 1934. It is a current report filing by a non-U.S. issuer, carrying an Exhibit press release. This matches the Regulatory Filings category for miscellaneous SEC notices and current reports by foreign issuers.
2026-05-29 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 85% confidence The document is a Form 6-K “Report of Foreign Private Issuer” filed under the Securities Exchange Act. It purely attaches a press release regarding an IRB approval and contains no actual financial statements or earnings information. It is a routine SEC current report by a foreign private issuer and fits the fallback “Regulatory Filings (RNS)” category, as it does not present the substantive content of an annual or interim report, earnings release, or other specific filing type.
2026-05-26 English
REPORT OF FOREIGN PRIVATE ISSUER
Capital/Financing Update Classification · 87% confidence The document is a Form 6-K filed by a foreign private issuer with the SEC, detailing amendments to securities purchase agreements, issuance of convertible promissory notes totaling up to $10 million, and conversion of notes into equity. The content is centered on fundraising and capital structure changes. This matches the definition of a Capital/Financing Update (CAP).
2026-05-19 English
REPORT OF FOREIGN PRIVATE ISSUER
Share Issue/Capital Change Classification · 90% confidence The document is a Form 6-K from a foreign private issuer, Clearmind Medicine Inc., announcing a reverse share split (1-for-10) and adjustments to share capital, including new CUSIP, rounding rules, and proportional adjustments for exercise prices and warrants. This fits the definition of a share capital change announcement (e.g., stock split). Therefore, the correct filing category is “Share Issue/Capital Change” (SHA).
2026-05-19 English
REPORT OF FOREIGN PRIVATE ISSUER
Capital/Financing Update Classification · 85% confidence The document is an SEC Form 6-K (Report of Foreign Private Issuer) that details an amendment to securities purchase agreements and the issuance of convertible promissory notes totaling $600,000. The primary purpose is to inform investors of a financing transaction (sale of notes), which falls under updates on company fundraising or capital structure changes.
2026-05-18 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.